Charles River Laboratories International has partnered with Israel’s Insightec (see here previously) to develop brain disease remedies. Insightec’s novel low-frequency ultrasound platform non-invasively disrupts the blood brain barrier, enabling drugs to be delivered to targeted brain areas.

https://www.ourcrowd.com/startup-news/charles-river-and-insightec-announce-strategic-collaboration-to-advance-therapeutic-development-utilizing-focused-ultrasound-in-neuroscience